AJOG MFM/LinkedIn
Dec 26, 2025, 13:09
Postpartum Readmission Rates Linked to Antihypertensive Choice – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“In a retrospective cohort of individuals with hypertensive disorders of pregnancy, discharge with labetalol rather than nifedipine was independently associated with increased risk of postpartum hospital readmission (9.2% vs 3.9%, P<.001).
Read the full text here.”
Title: Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy
Authors: Carrie Bennett, Lara Lemon, Kripa Venkatakrishnan, Sanjana Ghosh, Hyagriv Simhan, Alisse Hauspurg
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 19, 2026, 10:10Josefine Königbauer: Is GDM the Same Condition in Singleton and Twin Pregnancies?
-
Mar 19, 2026, 06:39John Aitken Introduces the Scale of the Fertility Crisis Around the World – RBMO
-
Mar 18, 2026, 14:49Asma Khalil: I am Incredibly Honoured to Be Recognised as Extraordinary Woman of the Year
-
Mar 18, 2026, 14:35Article Fees May Be Covered for Fellows – Fertility and Sterility
-
Mar 18, 2026, 14:24Christopher Robinson: Predicting Preterm Birth Through Cervical Softening
-
Mar 18, 2026, 13:27Programmed-Cycle Frozen Embryo Transfer as a Risk Factor for PAS – RBMO
-
Mar 18, 2026, 13:19Ronya Rubinstein: When Period Pain Isn’t Normal: The Reality of Endometriosis in Young Women
-
Mar 18, 2026, 12:53Fat, Sugar and Weight: The IVF Success Formula You Didn’t Know About – Fertility Plus
-
Mar 18, 2026, 12:38Christopher Robinson: Ultrasound Diagnosis of Early Pregnancy Loss in IVF